Status:
TERMINATED
Down Syndrome Speech Intelligibility Diagnostic Treatment Study
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Office of the Vice Chancellor for Research and Graduate Education
Wisconsin Alumni Research Foundation
Conditions:
Down Syndrome
Eligibility:
MALE
7-16 years
Phase:
NA
Brief Summary
The 'Down syndrome speech intelligibility diagnostic treatment study' is a pilot clinical intervention study assessing the efficacy of an integrative speech treatment approach for individuals with Dow...
Detailed Description
The 'Down syndrome speech intelligibility diagnostic treatment study' is a pilot clinical intervention study assessing the efficacy of an integrative speech treatment approach for individuals with Dow...
Eligibility Criteria
Inclusion
- Males with a diagnosis of Down syndrome between the ages of 7 and 16 years
- Primary language is English
- Interested in improving their speech intelligibility.
- All participants must consent/assent to participate. As this is a multiple single subject design, services are available to all motivated participants who are willing to commit to the time/durations described in the diagnostic treatment.
Exclusion
- Primary language is not American English
- Do not have a diagnosis of Down syndrome
- Female
- Ages birth-6 and 17 years or older
- Individuals who have a co-occurring diagnosis that affects communication abilities \[e.g., diagnosed as deaf with cochlear implants, Autism, only use an alternative/augmentative communication (AAC) device to communicate\],
- Severe hearing loss which will limit their ability to participate in the treatment
- Individuals with a known mild or moderate hearing loss or current speech- language therapy services will not be excluded, but this information will be requested in the Parent Questionnaire. In addition, access to their current individualized education program (IEP) will be requested.
Key Trial Info
Start Date :
September 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04059354
Start Date
September 5 2019
End Date
February 28 2020
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Waisman Center, 1500 Highland Avenue
Madison, Wisconsin, United States, 53705